Technology Transfer-Generics

Technology Transfer-Generics
Product Description

We collaborate with over 50,000 manufacturers in the generics industry who seek technology transfer partners worldwide. Our dedicated team will assist you in finding the most suitable partner in the EU, USA, LATAM, or Asia, providing comprehensive documentation and technical support to bring your product vision to life at your facility.

Read more Show less

Zymo Biotech

  • Country/Region:
    Germany
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Biopharmaceutical
View company profile
Categories
more categories Show less
Specifications
  • Details
    We collaborate with over 50,000 manufacturers in the generics industry who seek technology transfer partners worldwide. Our dedicated team will assist you in finding the most suitable partner in the EU, USA, LATAM, or Asia, providing comprehensive documentation and technical support to bring your product vision to life at your facility.
More specifications Fewer specifications

Zymo Biotech

  • Country/Region:
    Germany
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Biopharmaceutical
View company profile

More Products from Zymo Biotech (2)

  • Technology Transfer-Biosimilars

    Product Technology Transfer-Biosimilars

    "If you're interested in Tech Transfer projects, our team is well-prepared to assist you with Biosimilar products such as Insulin or Monoclonal Antibodies. We have a network of over 10,000 partners who are willing to explore these opportunities. Please don't hesitate to reach out for more information on th...
  • Technology Transfer-Vaccines

    Product Technology Transfer-Vaccines

    We collaborate with over 20,000 partners eager to initiate technology transfer projects. In particular, we have a strong presence in the vaccine sector. If you're interested in developing vaccine products, we can connect you with the most suitable partners worldwide.